

share
29-Nor-20-Oxolupeol CAS NO 19891-85-1
Unit Price:
CAS No.:19891-85-1
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
29-Nor-20-Oxolupeol is a specialized pentacyclic triterpenoid derivative, recognized for its unique structural framework and potential as a key synthetic intermediate. This compound matters to researchers and manufacturers seeking high-purity building blocks for the development of novel bioactive molecules. It is primarily needed by the pharmaceutical, nutraceutical, and advanced chemical synthesis industries for research and process development applications.
Application
- Pharmaceutical Research & Development: Serves as a critical intermediate in the synthesis of novel triterpenoid-based drug candidates, particularly for anti-inflammatory and metabolic disorder research.
- Natural Product Chemistry: Used as a reference standard or starting material for the semi-synthesis of complex natural products and their analogs for biological evaluation.
- Biochemical Studies: Employed in structure-activity relationship (SAR) studies to understand the biological role of modified triterpene scaffolds.
- Fine Chemical Synthesis: Acts as a versatile chiral building block for the preparation of high-value specialty chemicals and advanced materials.
- Academic Research: Utilized in universities and research institutes for exploratory organic synthesis and methodological development.
Basic Information
| Product Name | 29-Nor-20-Oxolupeol |
| CAS No. | 19891-85-1 |
| Molecular Formula | C29H46O2 |
| Molecular Weight | 426.68 g/mol |
| Synonyms | 29-Nor-20-oxolupeol; 20-Oxo-29-norlupeol; Lup-20(29)-en-3-ol, 29-nor-20-oxo-; 3-Hydroxy-29-norlupan-20-one; 29-Norlupan-20-one-3-ol; (3β)-29-Norlupan-20-one-3-ol |
| EINECS | Contact for details |
Quality Control
Our 29-Nor-20-Oxolupeol is produced under stringent quality management protocols. Each batch undergoes comprehensive analytical testing, including HPLC for purity and spectroscopic methods (NMR, IR, MS) for structural confirmation, to ensure it meets exacting research-grade specifications. A detailed Certificate of Analysis (COA) is provided with every shipment to guarantee traceability, purity, and consistency for your critical applications.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). The compound should be handled in a manner that minimizes exposure to moisture and air to maintain long-term stability.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification (IR) | Conforms to structure |
| Identification (HPLC) | Conforms to reference |
| Purity (HPLC) | ≥ 95.0% |
| Melting Point | Contact for details |
| Loss on Drying | ≤ 1.0% |
| Residue on Ignition | ≤ 0.5% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Parkeol CAS NO 514-45-4


(S)-(-)-Limonene CAS NO 5989-54-8


Terpinen-4-Ol CAS NO 562-74-3


Cedrene CAS NO 11028-42-5


β-Pinene CAS NO 127-91-3


3-Carene CAS NO 13466-78-9


Farnesene CAS NO 502-61-4


Glycyrrhizic Acid CAS NO 1405-86-3


Asiaticoside CAS NO 16830-15-2


Valerenic Acid CAS NO 3569-10-6


Asiatic Acid CAS NO 464-92-6


Zerumbone CAS NO 471-05-6


Cantharidin CAS NO 56-25-7


Madecassic Acid CAS NO 18449-41-7


Squalene CAS NO 111-02-4


D-(+)-Camphoric Acid CAS NO 124-83-4


Taraxerol CAS NO 127-22-0


Pimaric Acid CAS NO 127-27-5


1,2,3,4,4A,4B,5,6,7,9,10,10A-Dodecahydro-7-Isopropyl-1,4A-Dimethylphenanthren-1-Methanol CAS NO 127-36-6


Nopol CAS NO 128-50-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






